Search for: "Robert Gottlieb"
Results 101 - 120
of 293
Sort by Relevance
|
Sort by Date
15 Nov 2018, 10:00 pm
Gottlieb recognized JUUL’s effort but said that its “voluntary action is no substitute for regulatory steps FDA will soon take. [read post]
28 Sep 2018, 6:15 am
Rocks, Cleary Gottlieb Steen & Hamilton LLP, on Monday, September 24, 2018 Tags: Algorithmic trading, Compliance and disclosure interpretation, Disclosure, Financial regulation, Financial technology, FINRA, Money laundering, Securities regulation, Transparency, Treasury Department From Duty to Power Posted by Brett McDonnell (University of Minnesota), on Monday, September 24, 2018 Tags: Accountable Capitalism… [read post]
25 Sep 2018, 1:38 pm
— Steve Gottlieb’s latest book is Unfit for Democracy: The Roberts Court and The Breakdown of American Politics. [read post]
21 Sep 2018, 6:10 am
Schanzenbach (Northwestern University) and Robert H. [read post]
24 Aug 2018, 6:06 am
Choi (University of Virginia Law School), Andrew Lund (Villanova University), and Robert J. [read post]
17 Aug 2018, 6:16 am
Richman, Robert F. [read post]
24 Jul 2018, 9:01 pm
Dorf is the Robert S. [read post]
17 Jul 2018, 3:11 am
SEC Commissioner Robert Jackson has noted that this presents an arbitrage opportunity – and may weigh in favor of proactive, voluntary disclosure. [read post]
13 Jul 2018, 6:19 am
Kohn and Katy Yang, Cleary Gottlieb Steen & Hamilton LLP, on Sunday, July 8, 2018 Tags: Boards of Directors, ESG, No-action letters, Proxy access, SEC, Securities regulation, Shareholder proposals, Shareholder voting The Inapplicability of Corwin and Section 220 Posted by Sarah T. [read post]
8 Jun 2018, 6:47 am
Bieber, Cleary Gottlieb Steen & Hamilton LLP, on Sunday, June 3, 2018 Tags: Boards of Directors, Engagement, Index funds, Institutional Investors, Long-Term value, Proxy season, Shareholder meetings, Shareholder voting The Importance of Inferior Voting Rights in Dual-Class Firms Posted by Dov Solomon (Ramat Gan Law School), on Sunday, June 3, 2018 Tags: Agency costs, Boards of Directors, Capital… [read post]
9 May 2018, 9:00 pm
“We not only thank Representatives Aderholt and Bishop, but also thank President Trump for his support and FDA Commissioner Gottlieb for his leadership. [read post]
7 May 2018, 5:28 am
* According to Rudy Giuliani, if special counsel Robert Mueller issues a subpoena, Donald Trump "[doesn't] have to" comply with it. [read post]
3 May 2018, 9:30 pm
FDA Commissioner Scott Gottlieb said, “It is easy to see how a child could confuse these e-liquid products for something they believe they’ve consumed before—like a juice box. [read post]
27 Apr 2018, 6:01 am
Shareholder Activists and Tardy Director Nominations Posted by Steve Wolosky, Andrew Freedman, and Ron Berenblat, Olshan Frome Wolosky LLP, on Wednesday, April 25, 2018 Tags: Boards of Directors, Delaware law, Director nominations, Disclosure, Materiality, New York, Proxy season, Securities litigation, Shareholder activism, Shareholder nominations, Shareholder voting, State law A Look Under the Hood of Spotify’s Direct… [read post]
25 Apr 2018, 3:37 am
” With a question that became a lighter moment, Roberts expressed skepticism about the requirement that consideration be “respectful. [read post]
23 Mar 2018, 6:23 am
Morley (Yale Law School), on Tuesday, March 20, 2018 Tags: Arbitrage, Disclosure, Exchange-traded funds, Innovation, Investor protection, Management, Market efficiency, Mutual funds, Risk, Risk disclosure, SEC, Securities regulation, Systemic risk Corporate Governance: On the Front Line of America’s Cyber War Posted by Robert J. [read post]
9 Mar 2018, 6:06 am
Odell, and Jennifer Kennedy Park, Cleary Gottlieb Steen & Hamilton LLP, on Wednesday, March 7, 2018 Tags: Accountability, Boards of Directors, Compliance & ethics, Corporate culture, Disclosure, Management, Misconduct, Reputation, Risk, Risk management, Whistleblowers The Cost of Turning a Blind Eye Posted by Matthew Schoenfeld (Burford Capital), on Wednesday, March 7, 2018 Tags: Appraisal… [read post]
23 Feb 2018, 6:14 am
., on Friday, February 16, 2018 Tags: Board composition, Board oversight, Boards of Directors, Corporate culture, Corporate Social Responsibility, Diversity, Executive Compensation, Incentives, Management, Misconduct, Risk management Perpetual Dual-Class Stock: The Case Against Corporate Royalty Posted by Robert J. [read post]
25 Jan 2018, 9:30 pm
FDA Commissioner Scott Gottlieb said that individuals with an opioid addiction should “have access to safe and effective treatments and not be victimized by unscrupulous vendors” making “baseless claims. [read post]
17 Jan 2018, 9:30 am
Desan, Leo Gottlieb Professor of Law, Harvard Law School; Robert C. [read post]
